Next Article in Journal
ZEB1 in Pancreatic Cancer
Previous Article in Journal
Dermoscopy of Scalp Melanoma: Report of Three Cases
Cancers 2010, 2(3), 1602-1616; doi:10.3390/cancers2031602
Article

Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry

1
, 2,3,* , 1
, 4
, 2
, 1
, 1
, 5
, 2
, 5
 and 5
Received: 21 June 2010; in revised form: 5 August 2010 / Accepted: 16 August 2010 / Published: 18 August 2010
View Full-Text   |   Download PDF [157 KB, uploaded 18 August 2010]   |   Browse Figures
Abstract: Biliary tract cancers (BTCs) are lethal malignancies currently lacking satisfactory methods for early detection and accurate diagnosis. Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) is a promising diagnostic tool for this disease. In this pilot study, sera samples from 50 BTCs and 30 cholelithiasis patients as well as 30 healthy subjects from a population-based case-control study were randomly grouped into training set (30 BTCs, 20 cholelithiasis and 20 controls), duplicate of training set, and blind set (20 BTCs, 10 cholelithiasis and 10 controls); all sets were analyzed on Immobilized Metal Affinity Capture ProteinChips via SELDI-TOF-MS. A decision tree classifier was built using the training set and applied to all test sets. The classification tree constructed with the 3,400, 4,502, 5,680, 7,598, and 11,242 mass-to-charge ratio (m/z) protein peaks had a sensitivity of 96.7% and a specificity of 85.0% when comparing BTCs with non-cancers. When applied to the duplicate set, sensitivity was 66.7% and specificity was 70.0%, while in the blind set, sensitivity was 95.0% and specificity was 75.0%. Positive predictive values of the training, duplicate, and blind sets were 82.9%, 62.5% and 79.2%, respectively. The agreement of the training and duplicate sets was 71.4% (Kappa = 0.43, u = 3.98, P < 0.01). The coefficient of variations based on 10 replicates of one sample for the five differential peaks were 15.8–68.8% for intensity and 0–0.05% for m/z. These pilot results suggest that serum protein profiling by SELDI-TOF-MS may be a promising approach for identifying BTCs but low assay reproducibility may limit its application in clinical practice.
Keywords: biliary tract cancers (BTCs); surface-enhanced laser desorption/ionization mass spectrometry (SELDI-TOF-MS); tumor biomarker; protein profiling biliary tract cancers (BTCs); surface-enhanced laser desorption/ionization mass spectrometry (SELDI-TOF-MS); tumor biomarker; protein profiling
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Wang, W.-J.; Xu, W.-H.; Liu, C.-Z.; Rashid, A.; Cheng, J.-R.; Liao, P.; Hu, H.; Chu, L.W.; Gao, Y.-T.; Yu, K.; Hsing, A.W. Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry. Cancers 2010, 2, 1602-1616.

AMA Style

Wang W-J, Xu W-H, Liu C-Z, Rashid A, Cheng J-R, Liao P, Hu H, Chu LW, Gao Y-T, Yu K, Hsing AW. Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry. Cancers. 2010; 2(3):1602-1616.

Chicago/Turabian Style

Wang, Wen-Jing; Xu, Wang-Hong; Liu, Cha-Zhen; Rashid, Asif; Cheng, Jia-Rong; Liao, Ping; Hu, Heng; Chu, Lisa W.; Gao, Yu-Tang; Yu, Kai; Hsing, Ann W. 2010. "Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry." Cancers 2, no. 3: 1602-1616.


Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert